Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Halcyon Labs is a specialized pharmaceutical company based in India that focuses on the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs). Founded in 1982, the company has established a strong reputation as a leading producer of cardiovascular medications, particularly beta-blockers such as Atenolol and Metoprolol Succinate. Their manufacturing operations are centered in Gujarat and are conducted in compliance with World Health Organization Good Manufacturing Practices (WHO-GMP) standards. Halcyon Labs provides high-purity chemical intermediates and APIs to formulation companies worldwide, supporting the global supply chain for essential heart disease treatments. The company maintains a rigorous focus on process chemistry and quality control to meet stringent international regulatory requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Halcyon Labs.